Navigating Barriers and Facilitators of Implementation: Engaging the Right Stakeholders
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbvie; Bayer AG; Boehringer Ingelheim; Boston Scientific Corporation; Bristol-Myers Squibb; Celecor; Espero; Janssen; Medscape; Medtronic; Merck/Schering Plough; NIH; Novo Nordisk; Pfizer; Rhoshan; Roche; Abiomed; Anthos; Cardionomics; HengRui; NephroSynergy; Philips; REATA; Veralox Therapeutic, Inc.
- Grant Support/Research Contract - AstraZenca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi-Sankyo/Elil Lilly and Company; Glaxo SmithKline; Janssen; Medtronic Foundation; Novartis; Pfizer; Alnylam Pharma; Lilly; Philips
- Equity/Stock(s)/Options - Tenac.io